← back to search

Deveroux Ferguson

University of Arizona · US
Area of research
Cellular and Molecular Neuroscience · Behavioral Neuroscience
Research interest
Research interests include Neuroscience and Neuropharmacology Research, Neurotransmitter Receptor Influence on Behavior, Stress Responses and Cortisol, and Epigenetics and DNA Methylation.
h-index
32
citations
6,019
works
62
NIH funding
primary concept
email

Recent publications

SIRT1 Coordinates Transcriptional Regulation of Neural Activity and Modulates Depression-Like Behaviors in the Nucleus Accumbens
Biological Psychiatry 2024cited by 19position: lastdoi
Protocol for Xenium spatial transcriptomics studies using fixed frozen mouse brain sections
STAR Protocols 2024cited by 15position: middledoi
Early impairment of cortical circuit plasticity and connectivity in the 5XFAD Alzheimer’s disease mouse model
Translational Psychiatry 2022cited by 30position: middledoi
Disrupted Maturation of Prefrontal Layer 5 Neuronal Circuits in an Alzheimer’s Mouse Model of Amyloid Deposition
Neuroscience Bulletin 2022cited by 18position: middledoi
Shisa6 mediates cell-type specific regulation of depression in the nucleus accumbens
Molecular Psychiatry 2021cited by 24position: lastdoi
SIRT1 Mediates Depression-Like Behaviors in the Nucleus Accumbens
Journal of Neuroscience 2016cited by 156position: lastdoi
Role of Tet1 and 5-hydroxymethylcytosine in cocaine action
Nature Neuroscience 2015cited by 186position: middledoi
SIRT1-FOXO3a Regulate Cocaine Actions in the Nucleus Accumbens
Journal of Neuroscience 2015cited by 109position: firstdoi
Epigenetic basis of opiate suppression of Bdnf gene expression in the ventral tegmental area
Nature Neuroscience 2015cited by 106position: middledoi
Dishevelled-2 regulates cocaine-induced structural plasticity and Rac1 activity in the nucleus accumbens
Neuroscience Letters 2015cited by 17position: middledoi
Erratum to: Chronic cocaine-regulated epigenomic changes in mouse nucleus accumbens
Genome biology 2015cited by 1position: middledoi
Prefrontal Cortical Circuit for Depression- and Anxiety-Related Behaviors Mediated by Cholecystokinin: Role of ΔFosB
Journal of Neuroscience 2014cited by 296position: middledoi
β-catenin mediates stress resilience through Dicer1/microRNA regulation
Nature 2014cited by 240position: middledoi
Locus-specific epigenetic remodeling controls addiction- and depression-related behaviors
Nature Neuroscience 2014cited by 223position: middledoi
Chronic cocaine-regulated epigenomic changes in mouse nucleus accumbens
Genome biology 2014cited by 201position: middledoi
Nucleus Accumbens-Specific Interventions in RGS9-2 Activity Modulate Responses to Morphine
Neuropsychopharmacology 2014cited by 44position: middledoi
Morphine and cocaine increase serum‐ and glucocorticoid‐inducible kinase 1 activity in the ventral tegmental area
Journal of Neurochemistry 2014cited by 32position: middledoi
Locus-specific epigenetic reprogramming for the study of reward pathology
Drug and Alcohol Dependence 2014cited by 0position: middledoi
Stress and CRF gate neural activation of BDNF in the mesolimbic reward pathway
Nature Neuroscience 2013cited by 210position: middledoi
Essential Role of SIRT1 Signaling in the Nucleus Accumbens in Cocaine and Morphine Action
Journal of Neuroscience 2013cited by 134position: firstdoi
Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons
Nature 2012cited by 1,156position: middledoi
Rac1 is essential in cocaine-induced structural plasticity of nucleus accumbens neurons
Nature Neuroscience 2012cited by 192position: middledoi
BDNF Is a Negative Modulator of Morphine Action
Science 2012cited by 184position: middledoi
Serum Response Factor and cAMP Response Element Binding Protein Are Both Required for Cocaine Induction of ΔFosB
Journal of Neuroscience 2012cited by 79position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Eric J. Nestler · Allen Institute for Brain Science16 papers (2012–2016)Rachael L. Neve · Massachusetts General Hospital10 papers (2012–2016)Michelle S. Mazei‐Robison · Michigan State University10 papers (2012–2015)Jian Feng · Chinese Academy of Medical Sciences & Peking Union Medical College9 papers (2012–2015)HaoSheng Sun · Howard Hughes Medical Institute7 papers (2012–2015)Ja Wook Koo · Korea Institute of Brain Science7 papers (2012–2014)Li Shen · Allen Institute for Brain Science6 papers (2013–2015)Elizabeth A. Heller · Translational Therapeutics (United States)6 papers (2013–2015)Ning‐Yi Shao · University of Macau6 papers (2013–2015)Caroline Dias · University of Colorado System5 papers (2012–2015)Shenfeng Qiu · University of Arizona5 papers (2021–2024)Xiaokuang Ma · University of Arizona5 papers (2021–2024)Scott J. Russo · Allen Institute for Brain Science5 papers (2012–2014)Ezekiell Mouzon · Allen Institute for Brain Science5 papers (2012–2014)Vincent Vialou · Centre National de la Recherche Scientifique5 papers (2012–2015)Mary Kay Lobo · University of Maryland, Baltimore4 papers (2012–2014)Jing Wei · University of Arizona4 papers (2021–2024)Diane Damez-Werno · PTC Therapeutics (United States)4 papers (2012–2015)David Dietz · Global Alliance for Improved Nutrition4 papers (2012–2015)Pamela Kennedy · University of California, Los Angeles4 papers (2014–2015)